GT Biopharma, Inc. (GTBP)
0.7319
+0.07
(+10.89%)
USD |
NASDAQ |
Jan 15, 15:05
GT Biopharma SG&A Expense (TTM): 6.564M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 2.717B |
| SELLAS Life Sciences Group, Inc. | 11.21M |
| Lyell Immunopharma, Inc. | 49.04M |
| Plus Therapeutics, Inc. | 11.09M |
| Geron Corp. | 160.96M |